Martell Christopher
SEC CIK 1873465 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CADL | Candel Therapeutics, Inc. | Dir | 111.3K | $1.10M | — | 5 | 2021-07-29 | 2025-06-25 |
Most active insiders at CADL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Tak Paul Peter | CEO, Dir | — | $3.16M |
| 2 | Manning Paul B | Dir | $3.00M | — |
| 3 | Barone Francesca | CSO | — | $235.8K |
| 4 | Tyagarajan Seshu | CTO | — | $154.2K |
Martell Christopher made no open-market trades at CADL in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-06-26 | 2025-06-25 | CADL | Candel Therapeutics, Inc. | Martell Christopher | Dir | A - Grant | $4.67 | +111.3K | 111.3K | New | +$520.0K |
| MAI | 2023-02-17 | 2022-12-08+ | CADL | Candel Therapeutics, Inc. | Martell Christopher | Dir | P - Purchase | $1.89 | +27.0K | 128.1K | +27% | +$51.1K |
| M | 2022-12-12 | 2022-12-08+ | CADL | Candel Therapeutics, Inc. | Martell Christopher | Dir | P - Purchase | $1.89 | +27.0K | 152.0K | +22% | +$51.1K |
| DI | 2021-08-02 | 2021-07-29 | CADL | Candel Therapeutics, Inc. | Martell Christopher | Dir | C - Cnv Deriv | — | +283.5K | 283.5K | New | — |
| DI | 2021-08-02 | 2021-07-29 | CADL | Candel Therapeutics, Inc. | Martell Christopher | Dir | P - Purchase | $8.00 | +125.0K | 125.0K | New | +$1.00M |
Purchase Sale Sale after option exercise All abbreviations